Laman JD - Search Results

1

Automated glycan assembly of peptidoglycan backbone fragments.

Dallabernardina P, Benazzi V, Laman JD, Seeberger PH, Loeffler FF. Dallabernardina P, et al. Among authors: laman jd. Org Biomol Chem. 2021 Nov 25;19(45):9829-9832. doi: 10.1039/d1ob01987b. Org Biomol Chem. 2021. PMID: 34734957

2

Bacterial Peptidoglycan as a Driver of Chronic Brain Inflammation.

Laman JD, 't Hart BA, Power C, Dziarski R. Laman JD, et al. Trends Mol Med. 2020 Jul;26(7):670-682. doi: 10.1016/j.molmed.2019.11.006. Epub 2020 Feb 21. Trends Mol Med. 2020. PMID: 32589935 Review.

3

Assessment of microbiota and peptidoglycan in perianal fistulas.

van Onkelen RS, Mitalas LE, Gosselink MP, van Belkum A, Laman JD, Schouten WR. van Onkelen RS, et al. Among authors: laman jd. Diagn Microbiol Infect Dis. 2013 Jan;75(1):50-4. doi: 10.1016/j.diagmicrobio.2012.09.012. Epub 2012 Oct 25. Diagn Microbiol Infect Dis. 2013. PMID: 23102557

4

Multiple sclerosis - a response-to-damage model.

't Hart BA, Hintzen RQ, Laman JD. 't Hart BA, et al. Among authors: laman jd. Trends Mol Med. 2009 Jun;15(6):235-44. doi: 10.1016/j.molmed.2009.04.001. Epub 2009 May 18. Trends Mol Med. 2009. PMID: 19451035 Review.

5

EBV Infection and Multiple Sclerosis: Lessons from a Marmoset Model.

'tHart BA, Kap YS, Morandi E, Laman JD, Gran B. 'tHart BA, et al. Among authors: laman jd. Trends Mol Med. 2016 Dec;22(12):1012-1024. doi: 10.1016/j.molmed.2016.10.007. Epub 2016 Nov 8. Trends Mol Med. 2016. PMID: 27836419 Review.

6

Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12).

Laman JD, 't Hart BA, Brok H, Meurs Mv, Schellekens MM, Kasran A, Boon L, Bauer J, Boer Md, Ceuppens J. Laman JD, et al. Eur J Immunol. 2002 Aug;32(8):2218-28. doi: 10.1002/1521-4141(200208)32:8<2218::AID-IMMU2218>3.0.CO;2-0. Eur J Immunol. 2002. PMID: 12209634 Free article.

7

Modelling of multiple sclerosis: lessons learned in a non-human primate.

't Hart BA, Laman JD, Bauer J, Blezer E, van Kooyk Y, Hintzen RQ. 't Hart BA, et al. Among authors: laman jd. Lancet Neurol. 2004 Oct;3(10):588-97. doi: 10.1016/S1474-4422(04)00879-8. Lancet Neurol. 2004. PMID: 15380155 Review.

8

Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis.

't Hart BA, Hintzen RQ, Laman JD. 't Hart BA, et al. Among authors: laman jd. Neurodegener Dis. 2008;5(1):38-52. doi: 10.1159/000109937. Neurodegener Dis. 2008. PMID: 18075274 Review.

9

Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE.

van Zwam M, Huizinga R, Melief MJ, Wierenga-Wolf AF, van Meurs M, Voerman JS, Biber KP, Boddeke HW, Höpken UE, Meisel C, Meisel A, Bechmann I, Hintzen RQ, 't Hart BA, Amor S, Laman JD, Boven LA. van Zwam M, et al. Among authors: laman jd. J Mol Med (Berl). 2009 Mar;87(3):273-86. doi: 10.1007/s00109-008-0421-4. Epub 2008 Dec 3. J Mol Med (Berl). 2009. PMID: 19050840

10

Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development.

Kap YS, Laman JD, 't Hart BA. Kap YS, et al. Among authors: laman jd. J Neuroimmune Pharmacol. 2010 Jun;5(2):220-30. doi: 10.1007/s11481-009-9178-y. Epub 2009 Oct 14. J Neuroimmune Pharmacol. 2010. PMID: 19826959 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page